mimmunМедицинская иммунологияMedical Immunology (Russia)1563-06252313-741XSPb RAACI10.15789/1563-0625-QAO-2604mimmun-2604Research ArticleИММУНОЛОГИЧЕСКИЕ МЕТОДЫIMMUNOLOGICAL METHODSКоличественный анализ протективной активности Т-клеточного иммунитета к возбудителю бруцеллезаQuantitative analysis of protective T cell immunity against brucellosishttps://orcid.org/0000-0003-0422-6755ПономаренкоД. Г.PonomarenkoD. G.

Пономаренко Дмитрий Григорьевич – к.б.н., заведующий лабораторией бруцеллеза Кандидат биологических наук, заведующий лабораторией бруцеллёза 

Адрес для переписки:Пономаренко Дмитрий Григорьевич -ФКУЗ «Ставропольский противочумный институт» Роспотребнадзора355035, Россия, г. Ставрополь, ул. Советская, 13-15. Тел.: 8 (8652) 23-01-65 (доб. 119).Тел./факс: 8 (8652) 26-03-12.

Ponomarenko Dmitry Grigoryevich, PhD (Biology), Head, Laboratory of Brucellosis

Address for correspondence:Dmitry G. Ponomarenko –Stavropol Anti-Plague Institute 13-15 Sovetskaya StStavropol355035 Russian FederationPhone: +7 (8652) 23-01-65 (acc. 119).Phone/fax: +7 (8652) 26-03-12.

ponomarenko.dg@gmail.comhttps://orcid.org/0000-0001-6068-6655КостюченкоМ. В.KostyuchenkoM. V.

Костюченко Марина Владимировна – биолог сектора иммунологии и патоморфологии особо опасных инфекционных заболеваний 

г. Ставрополь

Kostyuchenko  Marina Vladimirovna, Biologist, Sector of Immunology and Pathomorphology of Particularly Dangerous Infectious Diseases

Stavropol

marina.costyucheno@yandex.ruhttps://orcid.org/0000-0001-6073-6544РакитинаЕ. Л.RakitinaE. L.

Ракитина Екатерина Львовна – к.м.н., врач КЛД сектора иммунологии и патоморфологии особо опасных инфекционных заболеваний

г. Ставрополь

Rakitina Ekaterina Lvovna, PhD (Medicine), Leading Research Associate, Sector of Immunology and Pathomorphology of Particularly Dangerous Infectious Diseases

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0003-1054-8937ЛогвиненкоО. В.LogvinenkoO. V.

Логвиненко Ольга Васильевна – к.б.н., заведующая сектором иммунологии и патоморфологии особо опасных инфекционных заболеваний 

г. Ставрополь

Logvinenko Olga Vasilievna, PhD (Biology), Head, Sector of Immunology and Pathomorphology of Particularly Dangerous Infectious Diseases

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0002-7459-7204ХачатуроваА. А.KhachaturovaA. A.

Хачатурова  Анна Андреевна – биолог лаборатории бруцеллеза 

г. Ставрополь

Khachaturova Anna Andreevna , Biologist, Laboratory of Brucellosis

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0001-7405-101XЛукашевичД. Е.LukashevichD. E.

Лукашевич Дарья Евгеньевна – младший научный сотрудник лаборатории бруцеллеза 

г. Ставрополь

Lukashevich Darya Evgenievna, Junior Research Associate, Laboratory of Brucellosis

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0002-3564-0791КурчеваС. А.KurchevaS. A.

Курчева  Светлана Александровна – к.б.н., ведущий научный сотрудник научно-производственной лаборатории препаратов для диагностики особо опасных и других инфекций

г. Ставрополь

Kurcheva  Svetlana Aleksandrovna , PhD (Biology), Leading Research Associate, Laboratory of Drugs for the Particularly Dangerous and Other Infections Diagnostic

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0003-2229-6570РусановаД. В.RusanovaD. V.

Русанова Диана Владимировна – к.м.н., заведующая научно-производственной лабораторией препаратов для диагностики особо опасных и других инфекций

г. Ставрополь

Rusanova iana Vladimirovna, PhD (Medicine), Head, Laboratory of Diagnostic Drugs for the Particularly Dangerous and Other Infections

Stavropol

stavnipchi@mail.ruhttps://orcid.org/0000-0002-9362-3949КуличенкоА. Н.KulichenkoA. N.

Куличенко Александр Николаевич – д.м.н., профессор, академик РАН, директор

г. Ставрополь

Kulichenko Alexander Nikolaevich, PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Director

Stavropol

stavnipchi@mail.ruФКУЗ «Ставропольский противочумный институт» РоспотребнадзораРоссияStavropol Anti-Plague InstituteRussian Federation202412092023261211220Copyright © Пономаренко Д.Г., Костюченко М.В., Ракитина Е.Л., Логвиненко О.В., Хачатурова А.А., Лукашевич Д.Е., Курчева С.А., Русанова Д.В., Куличенко А.Н., 20242024Пономаренко Д.Г., Костюченко М.В., Ракитина Е.Л., Логвиненко О.В., Хачатурова А.А., Лукашевич Д.Е., Курчева С.А., Русанова Д.В., Куличенко А.Н.Ponomarenko D.G., Kostyuchenko M.V., Rakitina E.L., Logvinenko O.V., Khachaturova A.A., Lukashevich D.E., Kurcheva S.A., Rusanova D.V., Kulichenko A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.mimmun.ru/mimmun/article/view/2604

We present the results of studies related to antigen reactivity of T lymphocyte population under ex vivo conditions and the intensity of protective post-vaccination immunity to causative agent of brucellosis. Due to peculiarities of immunopathogenesis in brucellosis infection and prevailing role of adaptive T cell immunity for protection against the causative agent of infection, a predictive evaluation of protective immunity against brucellosis using CAST-tests is considered the most important issue in the field. There is an obvious need for ex vivo analysis of correlations between the activity of antigen stimulation of T cells, and the intensity of protective immunity raised after vaccination. A close direct relationship was established between the number of live microbial cells of Brucella abortus 19BA vaccine strain administered, and increase in ex vivo CD3 cell activation. A close correlation (r = -0.841 ÷ -0.966, R2 = 0.708 ÷ 0.969) was revealed between ex vivo values of antigen-induced stimulation of CD3 lymphocytes, and the levels of post-vaccination immunological protection against brucellosis infection. We have shown that, in biomodels vaccinated against brucellosis with a T lymphocyte stimulation coefficient of 50% or more (according to intensity of antigen-induced ex vivo CD25 expression), 100% protection against brucellosis infection was achieved after contamination with Brucella melitensis at a dose of 1 × 103 live microbial cells. At the same time, a lack of a close correlation was noted between an increased dose of Brucella vaccine strain administered to biomodels, and a change in geometric mean of antibody titer (R2 = 0.357 ÷ 0.404), along with a weak relationship between the levels of agglutinins and immunological protection of biomodels from developing brucellosis infection and indices of bacterial contamination.

These results suggest an opportunity to quantify development and protective activity of T cell immunity to the causal agent of brucellosis based ex vivo levels of antigen reactivity of CD3 lymphocytes. A correlation analysis between the state of T cell antigen reactivity and immunological resistance to brucellosis infection indicated a high degree of closeness between these indices. The key influence on activity of protective immunity is exerted by the levels of antigen reactivity of T lymphocytes, whereas the quotient of antigenic stimulation in CD3+CD25+ population may be considered the most informative index of immune protective activity. The data obtained and the described methodology may be used as a predictive criterion in assessing protective level of cellular immunity to causative agent of brucellosis in vaccinated or recovering patients, testing the efficiency of specific prophylaxis in brucellosis and studying immunogenicity and protective properties of candidate vaccines against brucellosis.

The results of study relationship between antigen reactivity of T-lymphocyte population under ex vivo conditions and the intensity of protective post-vaccination immunity to causative agent of brucellosis are presented. Тaking into account the peculiarities of immunopathogenesis brucellosis and prevailing role of adaptive T-cell immunity to protect against the causative agent of infection, possibility predictive evaluation of protective immunity against brucellosis using CAST-tests is considered as the most important aspect of brucellosis problems. There is an obvious need for an ex vivo correlation analysis of the activity of antigen stimulation of T cells and the intensity of protective immunity formed after vaccination. A close direct proportional relationship was established between the number of live microbial cells Brucella abortus 19BA vaccine strain administered and increase in ex vivo CD3-cell activation. A close correlation was revealed between ex vivo value of antigen-induced stimulation CD3-lymphocytes and level of post-vaccination immunological protection against brucellosis infection. It has been shown that in biomodels vaccinated against brucellosis with a T-lymphocyte stimulation coefficient of 50% or more (according to intensity of antigen-induced ex vivo expression CD25), 100% protection from the development of brucellosis infection after infection with Brucella melitensis at a dose of 1 × 103 live microbial cells are provided. At the same time, there was a lack of a close correlation between an increase in the dose of brucella vaccine strain administered to biomodels and a change in geometric mean antibody titer, presence of a weakly pronounced relationship between level of agglutinins and immunological protection of biomodels from development brucellosis infection and indicators bacterial contamination body.Based on results of study, it was demonstrated that it is possible to quantify the formation and protective activity of T-cell immunity to causative agent of brucellosis based on analysis of level antigen reactivity of CD3-lymphocytes ex vivo. The data obtained and described methodological approach can be used as a predictive criterion in assessing protective level of cellular immunity to causative agent of brucellosis in vaccinated or recovering patients, as well as in order to analyze effectiveness of specific prophylaxis brucellosis and study immunogenicity and protective properties candidate for brucellosis vWe present the results of studies related to antigen reactivity of T lymphocyte population under ex vivo conditions and the intensity of protective post-vaccination immunity to causative agent of brucellosis. Due to peculiarities of immunopathogenesis in brucellosis infection and prevailing role of adaptive T cell immunity for protection against the causative agent of infection, a predictive evaluation of protective immunity against brucellosis using CAST-tests is considered the most important issue in the field. There is an obvious need for ex vivo analysis of correlations between the activity of antigen stimulation of T cells, and the intensity of protective immunity raised after vaccination. A close direct relationship was established between the number of live microbial cells of Brucella abortus 19BA vaccine strain administered, and increase in ex vivo CD3 cell activation. A close correlation (r = -0.841 ÷ -0.966, R2 = 0.708 ÷ 0.969) was revealed between ex vivo values of antigeninduced stimulation of CD3 lymphocytes, and the levels of post-vaccination immunological protection against brucellosis infection. We have shown that, in biomodels vaccinated against brucellosis with a T lymphocyte stimulation coefficient of 50% or more (according to intensity of antigen-induced ex vivo CD25 expression), 100% protection against brucellosis infection was achieved after contamination with Brucella melitensis at a dose of 1×103 live microbial cells. At the same time, a lack of a close correlation was noted between an increased dose of Brucella vaccine strain administered to biomodels, and a change in geometric mean of antibody titer (R2 = 0.357÷0.404), along with a weak relationship between the levels of agglutinins and immunological protection of biomodels from developing brucellosis infection and indices of in vivo bacterial contamination.These results suggest an opportunity to quantify development and protective activity of T cell immunity to the causal agent of brucellosis based ex vivo levels of antigen reactivity of CD3 lymphocytes. A correlation analysis between the state of T cell antigen reactivity and immunological resistance to brucellosis infection indicated a high degree of closeness between these indices. The key influence on activity of protective immunity is exerted by the levels of antigen reactivity of T lymphocytes, whereas the quotient of antigenic stimulation in CD3+CD25+ population may be considered the most informative index of immune protective activity. The data obtained and the described methodology may be used as a predictive criterion in assessing protective level of cellular immunity to causative agent of brucellosis in vaccinated or recovering patients, testing the efficiency of specific prophylaxis in brucellosis and studying immunogenicity and protective properties of candidate vaccines against brucellosis.

бруцеллезвакцинацияпротективный иммунитетантигенреактивность Т-лимфоцитовкоэффициент антигенной стимуляциииндекс инфицированностиbrucellosisvaccinationprotective immunityantigen reactivity of T lymphocytesantigenic stimulation coefficientinfection indexReferencesБруцеллёз. Современное состояние проблемы (издание второе, дополненное) / под ред. Г.Г. Онищенко, А.Н. Куличенко. – Н. Новгород: Союзполиграф, Кириллица, 2021 – 356 c.Brucellosis. The current state of the problem(second edition, supplemented) / Ed. G.G. Onishchenko, A.N. Kulichenko. Nizhniy Novgorod: Souzpoligaf, Kirillitsa, 2021. 356 p.Кайтмазова Е.И., Островская Н.Н. Сравнительная вирулентность разных биотипов бруцелл вида melinensis, abortus, suis / Журнал микробиологии, эпидемиологии и иммунобиологии. 1967. №2. с.66-69Kaitmazova E.I., Ostrovskaya N.N. Comparative virulence of different biotypes of Brucella species melinensis, abortus, suis. Zhurnal mikrobiologii epidemiologii i immunologii = Journal of Microbiology, Epidemiology and Immunobiology, 1967, no. 2, pp. 66-69. (In Russ.)Костюченко М.В., Пономаренко Д.Г., Ракитина Е.Л., Логвиненко О.В., Санникова И.В., Дейнека Д.А., Голубь О.Г. Перспектива оценки антигенреактивности лимфоцитов in vitro для диагностики острого бруцеллеза. Инфекция и иммунитет. 2017;7(1):91-96.Kostyuchenko M.V., Ponomarenko D.G., Rakitina E.L., Logvinenko O.V., Sannikova I.V., Deineka D.A., Golub O.G. Perspective of in vitro lymphocytes antigenicity evaluation for the diagnostics of acute brucellosis. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2017. Vol. 7, no. 1, pp. 91-96. (In Russ.) doi: 10.15789/2220-7619-2017-1-91-96.Костюченко М.В., Ракитина Е.Л., Пономаренко Д.Г., Логвиненко О.В., Курчева С.А., Бердникова Т.В., Русанова Д.В., Куличенко А.Н. Изучение формирования клеточного поствакцинального иммунитета против бруцеллеза в лимфоцитарных тестах in vitro c использованием экспериментального антигенного комплекса. Медицинская иммунология. 2019;21(3):547-554.Kostyuchenko M.V., Rakitina E.L., Ponomarenko D.G., Logvinenko O.V., Kurcheva S.A., Berdnikova T.V., Rusanova D.V., Kulichenko A.N. Studying development of post-vaccinal cellular immunity against brucellosis by means of lymphocyte in vitro tests using an experimental antigenic complex. Meditsinskaya immunologiya = Medical Immunology (Russia), 2019, Vol. 21, no. 3, pp. 547-554. (In Russ.) doi: 10.15789/1563-0625-2019-3-547-554.Литвинова Л. С., Гуцол А. А., Сохоневич Н. А., Кофанова К. А., Хазиахматова О. Г., Шуплецова В. В., Кайгородова Е. В., Гончаров А. Г. Основные поверхностные Маркеры функциональной активности Т-лимфоцитов // Медицинская иммунология. 2014. №1. C. 7-29.Litvinova L.S., Gutsol A.A., Sokhonevich N.A., Kofanova K.A., Khaziakhmatova O.G., Shupletsova V.V., Kaigorodova E.V., Goncharov A.G. Basic surface markers of functional activity T-lymphocytes. Meditsinskaya immunologiya = Medical Immunology (Russia), 2014, Vol. 16, no. 1, pp. 7-26. (In Russ.) doi: 10.15789/1563-0625-2014-1-7-26.Методические рекомендации МР 3.1.0207-20 «Цитометрический анализ антигенреактивности лейкоцитов in vitro для диагностики и оценки эффективности иммунопрофилактики бруцеллёза у людей» (дата обращения 01.08.2022).Methodological recommendations MR 3.1.0207-20 “Cytometric analysis of leukocyte antigenreactivity in vitro for the diagnosis and evaluation of the effectiveness of immunoprophylaxis of brucellosis in humans”. [Electronic resourse]. Access mode: https://base.garant.ru/402622756/. (Date of the application: August 1, 2022).Методические указания МУК 3.1.7.3402-16 «Эпидемиологический надзор и лабораторная диагностика бруцеллёза» (дата обращения 02.08.2022).Methodological guidelines of MUC 3.1.7.3402-16 “Epidemiological surveillance and laboratory diagnostics of brucellosis”. [Electronic resourse]. Accessmode: https://docs.cntd.ru/document/456083631. (Date of the application: August 2, 2022)Методические указания МУ 3.3.2.2124-06 «Контроль диагностических питательных сред по 6.биологическим показателям для возбудителей чумы, холеры, сибирской язвы, туляремии» (дата обращения 02.08.2022).Methodological guidelines of MU 3.3.2.2124-06 “Control of diagnostic nutrient media by biological indicators for pathogens of plague, cholera, anthrax, tularemia”. [Electronic resourse]. Access mode: https://docs.cntd.ru/ document/1200047517. (Date of the application: August 2, 2022).Пономаренко Д.Г., Саркисян Н.С., Куличенко А.Н. Патогенез бруцеллёза: анализ иммунопатологической концепции // Инфекционные болезни: новости, мнения, обучение. 2020. Т. 9, № 3. С. 96–105.Ponomarenko D.G., Sarkisyan N.S., Kulichenko A.N. Pathogenesisofbrucellosis: analysisoftheimmunopathological concept. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training, 2020, Vol. 9, no. 3, pp. 96-105. (In Russ.)Ременцова М.М., Грушина Т.А. Влияние гидрокортизона и методов заражения на высеваемость бруцелл из организма белых мышей / Журнал микробиологии, эпидемиологии и иммунобиологии. 1978. №1. с.61-65.Rementsova M.M., Grushina T.A. Effect of hydrocortisone and methods of infection on the isolation of Brucella from the body of albino mice. Zhurnal mikrobiologii epidemiologii i immunologii = Journal of Microbiology, Epidemiology and Immunobiology, 1978, no. 1, pp. 61-65. (In Russ.)11. СанПиН 3.3686-21 «Санитарно-эпидемиологические требования по профилактике инфекционных болезней». [Электронный ресурс]. Режим доступа: https://docs.cntd.ru/document/573660140. (Дата обращения: 01.08.2022).SanPiN 3.3686-21 “Sanitary and epidemiological requirements for the prevention of infectious diseases”. [Electronic resourse]. Access mode: https://docs.cntd.ru/document/573660140. (Date of the application: August 1, 2022).Способ оценки фактической привитости людей против бруцеллёза на ранних сроках после вакцинации/ Пономаренко Д.Г., Ракитина Е.Л., Костюченко М.В., Логвиненко О.В., Курчева С.А., Жарникова И.В., Русанова Д.В., Бердникова Т.В., Хачатурова А.А., Куличенко А.Н. Патент на изобретение RU 2714136 C1, 12.02.2020. Заявка № 2019109438 от 29.03.2019.Method for assessing actual vaccination of people against brucellosis in the early stages after vaccination / Ponomarenko D.G., Rakitina E.L., Kostyuchenko M.V., Logvinenko O.V., Kurcheva S.A., Zharnikova I.V., Rusanova D.V., Berdnikova T.V., Khachaturova A.A., Kulichenko A.N. Patent for invention RU 2714136 C1, 02/12/2020. Application no. 2019109438 dated 29.03.2019.Avila-Calderón, E. D., Flores-Romo, L., Sharon, W., Donis-Maturano, L., Becerril-García, M. A., Arreola, M., Reynoso, B. A., Güemes, F. S., Contreras-Rodríguez, A. (2020). Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen. Folia microbiologica, 65(1), 1–16.Avila-Calderón E.D., Flores-Romo L., Sharon W., Donis-Maturano L., Becerril-García M.A., Arreola M., Reynoso B.A., Güemes F.S., Contreras-Rodríguez A. Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen. Folia Microbiol. (Praha), 2020, Vol. 65, no. 1, pp. 1-16.Dancella M. Fernandes, Xiaosui Jiang, Jae Ho Jung, Cynthia L. Baldwin, Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308, FEMS Immunology & Medical Microbiology, Volume 16, Issue 3-4, December 1996, Pages 193–203,Fernandes D.M., Jiang X., Jung J.H., Baldwin C.L. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308. FEMS Immunol. Med. Microbiol., 1996, Vol. 16, no. 3-4, pp. 193-203.Gerber, W.A. Focus on Chronic Variable Immunodeficiency for Primary Care Practitioners, the Gatekeepers to Optimal Health Outcomes for Primary Immunodeficiency Syndromes. Curr Pediatr Rep 7, 130–144 (2019).Gerber W.A. Focus on chronic variable immunodeficiency for primary care practitioners, the gatekeepers to optimal health outcomes for primary immunodeficiency syndromes. Curr. Pediatr. Rep., 2019, Vol. 7, pp. 130-144.Hare S, Bayliss R, Baron C, Waksman G. A large domain swap in the VirB11 ATPase of Brucella suis leaves the hexameric assembly intact. J Mol Biol. 2006 Jun 30;360(1):56-66.Hare S., Bayliss R., Baron C., Waksman G. A large domain swap in the VirB11 ATPase of Brucella suis leaves the hexameric assembly intact. J. Mol. Biol., 2006, Vol. 360, no. 1, pp. 56-66.Holling T., Schooten E., Van den Elsen P. Function and Regulation of MHC Class II Molecules in T-Lymphocytes: Of Mice and Men. Human immunology. 65. 282-90. 10.1016/j.humimm.2004.01.005.1:2.Holling T., Schooten E., van den Elsen P. Function and regulation of MHC Class II Molecules in T-Lymphocytes: Of Mice and Men. Hum. Immunol., 2004, Vol. 65, no. 4, pp. 282-290.Jiao, H., Zhou, Z., Li, B., Xiao, Y., Li, M., Zeng, H., Guo, X., & Gu, G. (2021). The Mechanism of Facultative Intracellular Parasitism of Brucella. International journal of molecular sciences, 22(7), 3673.Jiao H., Zhou Z., Li B., Xiao Y., Li M., Zeng H., Guo X., GuG. The mechanism of facultative intracellular parasitism of brucella. Int. J. Mol. Sci., Vol. 22, no. 7, 3673. doi: 10.3390/ijms22073673.López-Santiago R, Sánchez-Argáez AB, De Alba-Núñez LG, Baltierra-Uribe SL, Moreno-Lafont MC. Immune Response to Mucosal Brucella Infection. Front Immunol. 2019 Aug 20;10:1759.López-Santiago R., Sánchez-Argáez A.B., de Alba-Núñez L.G., Baltierra-Uribe S.L., Moreno-Lafont M.C. Immuneresponsetomucosalbrucellainfection. Front. Immunol., 2019, Vol. 10, 1759. doi: 10.3389/fimmu.2019.01759.Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, Carlier Y, Letesson JJ, Muraille E. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun. 2012 Dec;80(12):4271-80.Vitry M.A., de Trez C., Goriely S., Dumoutier L., Akira S., Ryffel B., Carlier Y., Letesson J.J., Muraille E. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect. Immun., 2012, Vol. 80, no. 12, pp. 4271-4280.Xavier MN, Winter MG, Spees AM, Nguyen K, Atluri VL, Silva TM, Bäumler AJ, Müller W, Santos RL, Tsolis RM. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog. 2013;9(6):e1003454.Xavier M.N., Winter M.G., Spees A.M., Nguyen K., Atluri V.L., Silva T.M., Bäumler A.J., Müller W., Santos R.L., Tsolis R.M. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog., 2013, Vol. 9, no. 6, e1003454. doi: 10.1371/journal.ppat.1003454.

The authors declare that there are no conflicts of interest present.